Screening for colorectal neoplasia with faecal tests

被引：9
作者：
Fraser, Callum G. [1 ]
机构：
[1] Univ Dundee, Ctr Res Canc Prevent & Screening, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland
来源：
LANCET ONCOLOGY | 2011年 / 12卷 / 06期
关键词：
D O I：
10.1016/S1470-2045(11)70106-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：516 / 517
页数：2
相关论文
共 5 条
  • [1] Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests
    Brenner, Hermann
    Haug, Ulrike
    Hundt, Sabrina
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (07) : 1643 - 1649
  • [2] Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort
    Chen, Li-Sheng
    Yen, Amy Ming-Fang
    Chiu, Sherry Yueh-Hsia
    Liao, Chao-Sheng
    Chen, Hsiu-Hsi
    [J]. LANCET ONCOLOGY, 2011, 12 (06) : 551 - 558
  • [3] Higher Fecal Immunochemical Test Cutoff Levels: Lower Positivity Rates but Still Acceptable Detection Rates for Early-Stage Colorectal Cancers
    Droste, Jochim S. Terhaar Sive
    Oort, Frank A.
    van der Hulst, Rene W. M.
    van Heukelem, Henk A.
    Loffeld, Ruud J. L. F.
    van Turenhout, Sietze T.
    Ben Larbi, Ilhame
    Kanis, Shannon L.
    Neerincx, Maarten
    Raekers, Mirre
    Coupe, Veerle M. H.
    Bouman, Anneke A.
    Meijer, Gerrit A.
    Mulder, Chris J. J.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (02) : 272 - 280
  • [4] Fraser CG, 2011, CLIN LAB NEWS, V37, P8
  • [5] Segnan N, 2010, European guidelines for quality assurance in colorectal cancer screening and diagnosis, VFirst, P1
1